Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Segal

Showing results (321-330 of 675) with videos related to

Pageof 68
Sort By:
The Journal of Experimental Medicine|March 17, 1999
Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cellsJ T Chang, E M Shevach, B M Segal
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejectionBenjamin M Segal, Deborah D Glass, Ethan M Shevach
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Predicting Toll-like receptor structures and characterizing ligand bindingJoshua N Leonard, Jessica K Bell, David M Segal
Brain Research. Molecular Brain Research|May 1, 1997
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalitiesD M Segal, C T Moraes, D C Mash
Pharmacy (Basel, Switzerland)|July 30, 2020
The Expanding Role of the Oncology PharmacistLisa M Holle, Eve M Segal, Kate D Jeffers
Immunology Today|February 1, 1991
Bispecific antibodies and targeted cellular cytotoxicityM W Fanger, D M Segal, J L Romet-Lemonne
The Journal of Biological Chemistry|November 15, 1992
Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian rasM Segal, I Marbach, D Engelberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4A Visintin, A Mazzoni, J A Spitzer, et al.
Gynecologic Oncology|October 1, 1995
Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern--a case reportD Schneider, R Halperin, M Segal, et al.
Clinical and Laboratory Haematology|December 1, 1994
Unusual bleeding manifestations of amyloidosis in patients with multiple myelomaM Rapoport, R Yona, S Kaufman, et al.
Pageof 68

Showing results (321-330 of 675) with videos related to

Sort By:
Pageof 68
The Journal of Experimental Medicine|March 17, 1999
Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cellsJ T Chang, E M Shevach, B M Segal
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejectionBenjamin M Segal, Deborah D Glass, Ethan M Shevach
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Predicting Toll-like receptor structures and characterizing ligand bindingJoshua N Leonard, Jessica K Bell, David M Segal
Brain Research. Molecular Brain Research|May 1, 1997
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalitiesD M Segal, C T Moraes, D C Mash
Pharmacy (Basel, Switzerland)|July 30, 2020
The Expanding Role of the Oncology PharmacistLisa M Holle, Eve M Segal, Kate D Jeffers
Immunology Today|February 1, 1991
Bispecific antibodies and targeted cellular cytotoxicityM W Fanger, D M Segal, J L Romet-Lemonne
The Journal of Biological Chemistry|November 15, 1992
Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian rasM Segal, I Marbach, D Engelberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4A Visintin, A Mazzoni, J A Spitzer, et al.
Gynecologic Oncology|October 1, 1995
Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern--a case reportD Schneider, R Halperin, M Segal, et al.
Clinical and Laboratory Haematology|December 1, 1994
Unusual bleeding manifestations of amyloidosis in patients with multiple myelomaM Rapoport, R Yona, S Kaufman, et al.
Pageof 68